The SMYD3 protein is frequently overexpressed in human cancers; it recognizes specific DNA sequences and has been reported to act as an epigenetic regulator through tri-methylation of histone residues H3K4, H4K5 and H4K2032–34. This evidence concerns the gene SMYD3 and cancer.